PYXS — Pyxis Oncology, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1782223 ·
Last close
$1.44
Market Cap
$172.24M
52W High
$5.55
52W Low
$1.03
ADV30
837,799
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 0 | — | -25,990,000 | -25,346,000 | 54,922,000 | 18,855,000 | 43,482,000 |
| Mar 2026 | 0 | — | -24,360,000 | -23,272,000 | 64,300,000 | 5,766,000 | 33,032,000 |
| Dec 2025 | 11,038,000 | 8,650,000 | -18,295,000 | -18,106,000 | 91,520,000 | 15,422,000 | 38,112,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-67,910,000
Investing CF
$65,402,000
Financing CF
$10,630,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.36
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-491,795,000
Inventory
—
Receivables
$700,000
ST Investments
$14,141,000
EBIT TTM
$-92,106,000
Pretax Income TTM
$-87,624,000
Interest Exp TTM
—
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$11,038,000
EBITDA
$-85,526,000
Free Cash Flow
$-23,186,750
Enterprise Value
$119,122,960
Total Cash
$32,996,000
Total Debt
$17,832,000
Shares Out
119,607,855
Trailing EPS
$-1.27
Book Value
$0.85
ROE
-179.1%
ROA
-63.0%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,858,000 | -84,420,000 | -79,621,000 | 91,520,000 | 38,112,000 | 53,408,000 | -63,502,000 |
| Dec 2024 | 16,146,000 | -68,496,000 | -77,331,000 | 157,181,000 | 36,430,000 | 120,751,000 | -57,672,000 |
| Dec 2023 | 0 | -82,196,000 | -73,790,000 | 173,726,000 | 48,022,000 | 125,704,000 | -70,709,000 |
| Dec 2022 | 0 | -123,481,000 | -120,717,000 | 211,379,000 | 50,555,000 | 160,824,000 | -89,335,000 |
TTM Snapshot
Revenues TTM
$6,662,000
NetIncome TTM
$-88,727,000
OpCashFlow TTM
—
Assets (Latest)
$54,922,000
Forward EPS
$-0.88
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $1.39 · call volume: 22 · put volume: 50Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SLGL | Sol-Gel Technologies Ltd. | $172.97M | $52.83 | — |
| IFRX | InflaRx N.V. | $169.47M | $1.15 | — |
| KRRO | Korro Bio, Inc. | $169.10M | $12.32 | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | $168.29M | $3.87 | — |
| ELDN | Eledon Pharmaceuticals, Inc. | $167.23M | $1.98 | — |
News headlines (Yahoo Finance, 1h cache)
Pyxis Oncology to Host Live Webcast on Updated MICVO Phase 1 Monotherapy Data Demonstrating Durable Response in 2L+ R/M HNSCC Following Late-Breaking Oral Presentation at EORTC-NCI-AACR Symposium
2026-11-18 23:01 · Yahoo
Pyxis Oncology Catalysts on Track With Upcoming Trial Results in Head, Neck Cancer Treatment, RBC Says
2026-11-06 16:33 · Yahoo
Pyxis Oncology Reports Third Quarter 2026 Financial Results and Highlights Progress Toward Pivotal Development of Micvotabart Pelidotin (MICVO)
2026-11-05 12:00 · Yahoo
Pyxis Oncology to Participate in Upcoming Investor Conferences
2026-10-28 11:30 · Yahoo
Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Ca
2026-10-27 12:45 · Yahoo
Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering
2026-10-02 11:00 · Yahoo
Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
2026-09-30 05:11 · Yahoo
Pyxis Oncology Announces Proposed Public Offering
2026-09-29 20:24 · Yahoo
Pyxis Oncology shares fall 7% despite updated MICVO trial results
2026-09-09 14:08 · Yahoo
Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+
2026-09-09 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.